All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Clinical and Guideline Updates on Systemic Therapies for Hepatocellular Carcinoma

Wednesday, May 18, 2022, 6:00 PM - 7:00 PM ET
  -  Register



Activity Description

Join us for this dynamic 1-hour CPE-certified live webinar, in which an expert pharmacist panel will discuss current guidance and emerging strategies for treating patients with early and advanced HCC. Sign up now!

Target Audience

The target audience for this activity is pharmacists, including clinical, managed care, and specialty pharmacists, who care for patients with HCC as well as other stakeholders in hematology/oncology practice.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Evaluate clinical data on the use of systemic treatment approaches for patients with early or intermediate-stage HCC.
  • Design optimal, individualized care plans for patients with advanced HCC, both in the frontline and second-line treatment settings.
  • Develop strategies to identify and mitigate unique adverse events associated with novel targeted therapies in patients with HCC.
  • Identify patients who may benefit from ongoing clinical trials based on tumor characteristics, previous treatment, and patient characteristics and preferences.


Courtney C. Cavalieri, PharmD, BCOP
Clinical Oncology Pharmacist
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah

Amber Draper, PharmD, BCOP
Oncology Clinical Pharmacy Specialist
Clinical Coordinator, Oncology
Emory Healthcare Winship Cancer Institute
Atlanta, Georgia

CE Accreditation


ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-159-L01-P has been assigned to this live application-based activity (initial release date 5-18-22). This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.


ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.


This activity is supported by an educational grant from AstraZeneca.


The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.